This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Fraenkel M, Kim MK, Faggiano A, Valk GD. Epidemiology of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol 2012; 26: 691-703. doi: 10.1016/j.bpg.2013.01.006FraenkelMKimMKFaggianoAValkGDEpidemiology of gastroenteropancreatic neuroendocrine tumoursBest Pract Res Clin Gastroenterol20122669170310.1016/j.bpg.2013.01.00623582913Open DOISearch in Google Scholar
Oberg K, Akerström G, Rindi G, Jelic S; ESMO Guidelines Working Group. Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 (Suppl 5): v223-7. doi: 10.1093/annonc/mdq192ObergKAkerströmGRindiGJelicSESMO Guidelines Working Group. Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201021Suppl 5v223710.1093/annonc/mdq19220555086Open DOISearch in Google Scholar
Modlin IM, Moss SF, Chung DC, Jensen RT, Snyderwine E. Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors. J Natl Cancer Inst 2008; 100: 1282-9. doi: 10.1093/jnci/djn275ModlinIMMossSFChungDCJensenRTSnyderwineEPriorities for improving the management of gastroenteropancreatic neuroendocrine tumorsJ Natl Cancer Inst20081001282910.1093/jnci/djn275253854918780869Open DOISearch in Google Scholar
Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, Caplin M, et al. ENETS Consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine Tumors. Neuroendocrinology 2016; 103: 153-71. doi: 10.1159/000443171FalconiMErikssonBKaltsasGBartschDKCapdevilaJCaplinMENETS Consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine TumorsNeuroendocrinology20161031537110.1159/000443171484988426742109Open DOISearch in Google Scholar
Pavel M, O’Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, et al. ENETS Consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology 2016; 103: 172-85. doi: 10.1159/000443167PavelMO’TooleDCostaFCapdevilaJGrossDKianmaneshRENETS Consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary siteNeuroendocrinology20161031728510.1159/00044316726731013Open DOISearch in Google Scholar
Sundin A. Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol 2012; 26: 803-18. doi: 10.1016/j.bpg.2012.12.004SundinARadiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumoursBest Pract Res Clin Gastroenterol2012268031810.1016/j.bpg.2012.12.00423582920Open DOISearch in Google Scholar
Yu R, Wachsman A. Imaging of neuroendocrine tumors: indications, interpretations, limits, and pitfalls. Endocrinol Metab Clin North Am 2017; 46: 795-814. doi: 10.1016/j.ecl.2017.04.008YuRWachsmanAImaging of neuroendocrine tumors: indications, interpretations, limits, and pitfallsEndocrinol Metab Clin North Am20174679581410.1016/j.ecl.2017.04.00828760239Open DOISearch in Google Scholar
Rockall AG, Reznek RH. Imaging of neuroendocrine tumours (CT/MR/US). Best Pract Res Clin Endocrinol Metab 2007; 21: 43-68. doi: 10.1016/j. beem.2007.01.003RockallAGReznekRHImaging of neuroendocrine tumours (CT/MR/US)Best Pract Res Clin Endocrinol Metab200721436810.1016/j.beem.2007.01.00317382265Open DOISearch in Google Scholar
Gatto F, Hofland LJ. The role of somatostatin and dopamine D2 receptors in endocrine tumors. Endocr Relat Cancer 2011; 18: R233-R251. doi: 10.1530/ERC-10-0334GattoFHoflandLJThe role of somatostatin and dopamine D2 receptors in endocrine tumorsEndocr Relat Cancer201118R233R25110.1530/ERC-10-033422135243Open DOISearch in Google Scholar
Rust E, Hubele F, Marzano E, Goichot B, Pessaux P, Kurtz JE, et al. Nuclear medicine imaging of gastro-entero-pancreatic neuroendocrnne tumors. The key role of cellular differentiation and tumor grade: from theory to clinical practice. Cancer Imaging 2012; 12: 173-84. doi: 10.1102/1470-7330.2012.0026RustEHubeleFMarzanoEGoichotBPessauxPKurtzJENuclear medicine imaging of gastro-entero-pancreatic neuroendocrnne tumors. The key role of cellular differentiation and tumor grade: from theory to clinical practiceCancer Imaging2012121738410.1102/1470-7330.2012.0026339278322743056Open DOISearch in Google Scholar
Auernhammer CJ, Spitzweg C, Angele MK, Boeck S, Grossman A, Nölting S, et al. Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies. Lancet Diabetes Endocrinol 2018; 6: 404-15. doi: 10.1016/S2213-8587(17)30401-1AuernhammerCJSpitzwegCAngeleMKBoeckSGrossmanANöltingSAdvanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategiesLancet Diabetes Endocrinol201864041510.1016/S2213-8587(17)30401-1Open DOISearch in Google Scholar
Bodei L, Sundin A, Kidd M, Prasad V, Modlin IM. The status of neuroendocrine tumor imaging: from darkness to light? Neuroendocrinology 2015; 101: 1-17. doi: 10.1159/000367850.BodeiLSundinAKiddMPrasadVModlinIMThe status of neuroendocrine tumor imaging: from darkness to light?Neuroendocrinology201510111710.1159/00036785025228173Open DOISearch in Google Scholar
Sundin A, Arnold R, Baudin E, Cwikla JB, Eriksson B, Fanti S, et al. ENETS Consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imaging. Neuroendocrinology 2017; 105: 212-44. doi: 10.1159/000471879SundinAArnoldRBaudinECwiklaJBErikssonBFantiSENETS Consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imagingNeuroendocrinology20171052124410.1159/00047187928355596Open DOISearch in Google Scholar
Delle Fave G, O’Toole D, Sundin A, Taal B, Ferolla P, Ramage JK, et al; Vienna Consensus conference participants. ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms. Neuroendocrinology 2016; 103: 119-24. doi: 10.1159/000443168DelleFave GO’TooleDSundinATaalBFerollaPRamageJKVienna Consensus conference participants. ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasmsNeuroendocrinology20161031192410.1159/00044316826784901Open DOISearch in Google Scholar
Garcia-Carbonero R, Sorbye H, Baudin E, Raymond E, Wiedenmann B, Niederle B, et al. ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine zumors and neuroendocrine carcinomas. Neuroendocrinology 2016; 103: 186-94. doi: 10.1159/000443172Garcia-CarboneroRSorbyeHBaudinERaymondEWiedenmannBNiederleBENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine zumors and neuroendocrine carcinomasNeuroendocrinology20161031869410.1159/00044317226731334Open DOISearch in Google Scholar
Klöppel G, Couvelard A, Perren A, Komminoth P, McNicol AM, Nilsson O, et al. Mallorca consensus conference participants; European Neuroendocrine Tumor Society. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 2009; 90: 162-6. doi: 10.1159/000182196KlöppelGCouvelardAPerrenAKomminothPMcNicolAMNilssonOMallorca consensus conference participants; European Neuroendocrine Tumor Society. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratificationNeuroendocrinology200990162610.1159/00018219619060454Open DOISearch in Google Scholar
O’Toole D, Kianmanesh R, Caplin M. ENETS 2016 consensus guidelines for the management of patients with digestive neuroendocrine tumors: an update. Neuroendocrinology 2016; 103: 117-8. doi: 10.1159/000443169O’TooleDKianmaneshRCaplinMENETS 2016 consensus guidelines for the management of patients with digestive neuroendocrine tumors: an updateNeuroendocrinology2016103117810.1159/00044316926731186Open DOISearch in Google Scholar
Niederle B, Pape UF, Costa F, Gross D, Kelestimur F, Knigge U, et al. ENETS consensus guidelines update for neuroendocrine neoplasms of the jejunum and ileum. Neuroendocrinology 2016; 103: 125-38. doi: 10.1159/000443170NiederleBPapeUFCostaFGrossDKelestimurFKniggeUENETS consensus guidelines update for neuroendocrine neoplasms of the jejunum and ileumNeuroendocrinology20161031253810.1159/00044317026758972Open DOISearch in Google Scholar
Ramage JK, De Herder WW, Delle Fave G, Ferolla P, Ferone D, Ito T, et al. ENETS consensus guidelines update for colorectal neuroendocrine neoplasms. Neuroendocrinology 2016; 103: 139-43. doi: 10.1159/000443166RamageJKDe HerderWWDelleFave GFerollaPFeroneDItoTENETS consensus guidelines update for colorectal neuroendocrine neoplasmsNeuroendocrinology20161031394310.1159/00044316626730835Open DOISearch in Google Scholar
Etchebehere EC, de Oliveira Santos A, Gumz B, Vicente A, Hoff PG, Corradi G, et al. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial. J Nucl Med 2014; 55: 1598-604. doi: 10.2967/jnumed.114.144543EtchebehereECde OliveiraSantos AGumzBVicenteAHoffPGCorradiG68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trialJ Nucl Med201455159860410.2967/jnumed.114.14454325168627Open DOISearch in Google Scholar
Sahani DV, Bonaffini PA, Fernández-Del Castillo C, Blake MA. Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. Radiology 2013; 266: 38-61. doi: 10.1148/radiol.12112512SahaniDVBonaffiniPAFernández-Del CastilloCBlakeMAGastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and managementRadiology2013266386110.1148/radiol.1211251223264526Open DOISearch in Google Scholar
Baumann T, Rottenburger C, Nicolas G, Wild D. Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging. Best Pract Res Clin Endocrinol Metab 2016; 30: 45-57. doi: 10.1016/j.beem.2016.01.003BaumannTRottenburgerCNicolasGWildDGastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and stagingBest Pract Res Clin Endocrinol Metab201630455710.1016/j.beem.2016.01.00326971843Open DOISearch in Google Scholar
Kamaoui I, De-Luca V, Ficarelli S, Mennesson N, Lombard-Bohas C, Pilleul F. Value of CT enteroclysis in suspected small-bowel carcinoid tumors. AJR Am J Roentgenol 2010; 194: 629-33. doi: 10.2214/AJR.09.2760KamaouiIDe-LucaVFicarelliSMennessonNLombard-BohasCPilleulFValue of CT enteroclysis in suspected small-bowel carcinoid tumorsAJR Am J Roentgenol20101946293310.2214/AJR.09.276020173138Open DOISearch in Google Scholar
Tan EH, Tan CH. Imaging of gastroentero- pancreatic neuroendocrine tumors. World J Clin Oncol 2011; 2: 28-43. doi: 10.5306/wjco.v2.i1.28TanEHTanCHImaging of gastroentero- pancreatic neuroendocrine tumorsWorld J Clin Oncol20112284310.5306/wjco.v2.i1.28309546321603312Open DOISearch in Google Scholar
Woodard PK, Feldman JM, Paine SS, Baker ME. Midgut carcinoid tumors: CT findings and biochemical profiles. J Comput Assist Tomogr 1995; 19: 400-5.WoodardPKFeldmanJMPaineSSBakerMEMidgut carcinoid tumors: CT findings and biochemical profilesJ Comput Assist Tomogr199519400510.1097/00004728-199505000-00012Search in Google Scholar
Granata V, Fusco R, Avallone A, Catalano O, Piccirillo M, Palaia R, et al. A radiologist’s point of view in the presurgical and intraoperative setting of colorectal liver metastases. Future Oncol 2018; 14: 2189-206. doi: 10.2217/fon-2018-0080GranataVFuscoRAvalloneACatalanoOPiccirilloMPalaiaRA radiologist’s point of view in the presurgical and intraoperative setting of colorectal liver metastasesFuture Oncol201814218920610.2217/fon-2018-008030084273Open DOISearch in Google Scholar
Granata V, Fusco R, Catalano O, Avallone A, Palaia R, Botti G, et al. Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases. PLoS One 2017; 12: e0179951. doi: 10.1371/journal. pone.0179951GranataVFuscoRCatalanoOAvalloneAPalaiaRBottiGDiagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastasesPLoS One201712e017995110.1371/journal.pone.0179951547813628632786Open DOISearch in Google Scholar
Granata V, Fusco R, Catalano O, Avallone A, Leongito M, Izzo F, et al. Peribiliary liver metastases MR findings. Med Oncol 2017; 34: 124. doi: 10.1007/s12032-017-0981-7GranataVFuscoRCatalanoOAvalloneALeongitoMIzzoFPeribiliary liver metastases MR findingsMed Oncol20173412410.1007/s12032-017-0981-728573638Open DOISearch in Google Scholar
Granata V, Fusco R, Catalano O, Filice S, Avallone A, Piccirillo M, et al. Uncommon neoplasms of the biliary tract: radiological findings. Br J Radiol 2017; 90: 20160561. doi: 10.1259/bjr.20160561GranataVFuscoRCatalanoOFiliceSAvalloneAPiccirilloMUncommon neoplasms of the biliary tract: radiological findingsBr J Radiol2017902016056110.1259/bjr.20160561585334928731820Open DOISearch in Google Scholar
Granata V, Cascella M, Fusco R, dell’Aprovitola N, Catalano O, Filice S, et al. Immediate adverse reactions to Gadolinium-Based MR contrast media: A retrospective analysis on 10,608 examinations. Biomed Res Int 2016; 2016: 3918292. doi: 10.1155/2016/3918292GranataVCascellaMFuscoRdell’AprovitolaNCatalanoOFiliceSImmediate adverse reactions to Gadolinium-Based MR contrast media: A retrospective analysis on 10,608 examinationsBiomed Res Int20162016391829210.1155/2016/3918292501993627652261Open DOISearch in Google Scholar
Kulke MH, Anthony LB, Bushnell DL, de Herder WW, Goldsmith SJ, Klimstra DS, et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas 2010; 39: 735-52. doi: 10.1097/MPA.0b013e3181ebb168KulkeMHAnthonyLBBushnellDLde HerderWWGoldsmithSJKlimstraDSNANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreasPancreas2010397355210.1097/MPA.0b013e3181ebb168310072820664472Open DOISearch in Google Scholar
Cambruzzi E, Azeredo AM, Kronhart A, Foltz KM, Zettler CG, Pêgas KL. The presence of metastases in regional lymph nodes is associated with tumor size and depth of invasion in sporadic gastric adenocarcinoma. Arq Bras Cir Dig 2014; 27: 18-21. doi: 10.1590/S0102-67202014000100005CambruzziEAzeredoAMKronhartAFoltzKMZettlerCGPêgasKLThe presence of metastases in regional lymph nodes is associated with tumor size and depth of invasion in sporadic gastric adenocarcinomaArq Bras Cir Dig201427182110.1590/S0102-67202014000100005467547224676292Open DOISearch in Google Scholar
Scherübl H, Jensen RT, Cadiot G, Stölzel U, Klöppel G. Neuroendocrine tumors of the small bowels are on the rise: Early as- pects and management. World J Gastroin- test Endosc 2010; 2: 325-34. doi: 10.4253/wjge.v2.i10.325ScherüblHJensenRTCadiotGStölzelUKlöppelGNeuroendocrine tumors of the small bowels are on the rise: Early as- pects and managementWorld J Gastroin- test Endosc201023253410.4253/wjge.v2.i10.325299881821160582Open DOISearch in Google Scholar
Oberg K, Castellano D. Current knowledge on diagnosis and staging of neuroendocrine tumors. Cancer Metastasis Rev 2011; 30 (Suppl 1): 3-7. doi: 10.1007/s10555-011-9292-1ObergKCastellanoDCurrent knowledge on diagnosis and staging of neuroendocrine tumorsCancer Metastasis Rev201130Suppl 13710.1007/s10555-011-9292-121311954Open DOISearch in Google Scholar
Turaga KK, Kvols LK. Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin 2011; 61: 113-32. doi: 10.3322/caac.20097TuragaKKKvolsLKRecent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumorsCA Cancer J Clin2011611133210.3322/caac.2009721388967Open DOISearch in Google Scholar
Chang S, Choi D, Lee SJ, Lee WJ, Park MH, Kim SW, et al. Neuro-endocrine neoplasms of the gastrointestinal tract: classification, pathologic basis, and imaging features. RadioGraphics 2007; 27: 1667-79. doi: 10.1148/rg.276075001ChangSChoiDLeeSJLeeWJParkMHKimSWNeuro-endocrine neoplasms of the gastrointestinal tract: classification, pathologic basis, and imaging featuresRadioGraphics20072716677910.1148/rg.27607500118025510Open DOISearch in Google Scholar
Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97: 934-59. doi: 10.1002/cncr.11105ModlinIMLyeKDKiddMA 5-decade analysis of 13,715 carcinoid tumorsCancer2003979345910.1002/cncr.1110512569593Open DOISearch in Google Scholar
Masselli G, Polettini E, Casciani E, Bertini L, Vecchioli A, Gualdi G. Small-bowel neo- plasms: prospective evaluation of MR en- teroclysis. Radiology 2009; 251: 743-50. doi: 10.1148/radiol.2513081819MasselliGPolettiniECascianiEBertiniLVecchioliAGualdiGSmall-bowel neo- plasms: prospective evaluation of MR en- teroclysisRadiology20092517435010.1148/radiol.251308181919304922Open DOISearch in Google Scholar
Van Weyenberg SJ, Meijerink MR, Jacobs MA, Van der Peet DL, Van Kuijk C, Mulder CJ, et al. MR enteroclysis in the diagno- sis of small-bowel neoplasms. Radiology 2010; 254: 765-73. doi: 10.1148/radiol.09090828VanWeyenberg SJMeijerinkMRJacobsMAVander Peet DLVanKuijk CMulderCJMR enteroclysis in the diagno- sis of small-bowel neoplasmsRadiology20102547657310.1148/radiol.0909082820177091Open DOISearch in Google Scholar
Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP, et al. World Federation for Ultrasound in Medicine; European Federation of Societies for Ultrasound. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 2013; 39: 187-210. doi: 10.1016/j.ultrasmedbio.2012.09.002ClaudonMDietrichCFChoiBICosgroveDOKudoMNolsøeCPWorld Federation for Ultrasound in Medicine; European Federation of Societies for Ultrasound. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2010: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUSUltrasound Med Biol20133918721010.1016/j.ultrasmedbio.2012.09.00223137926Open DOISearch in Google Scholar
Shapiro R, Eldar S, Sadot E, Papa MZ, Zip- pel DB. Appendiceal carcinoid at a large tertiary center: pathologic findings and long-term follow-up evaluation. Am J Surg 2011; 201: 805-8. doi: 10.1016/j.amjsurg.2010.04.016ShapiroREldarSSadotEPapaMZZippelDBAppendiceal carcinoid at a large tertiary center: pathologic findings and long-term follow-up evaluationAm J Surg2011201805810.1016/j.amjsurg.2010.04.016Open DOISearch in Google Scholar
Kobayashi K, Katsumata T, Yoshizawa S, Sada M, Igarashi M, Saigenji K, et al. Indications of endoscopic polypectomy for rectal carcinoid tumors and clinical use- fulness of endoscopic ultrasonography. Dis Colon Rectum 2005; 48: 285-91. doi: 10.1007/s10350-004-0765-yKobayashiKKatsumataTYoshizawaSSadaMIgarashiMSaigenjiKIndications of endoscopic polypectomy for rectal carcinoid tumors and clinical use- fulness of endoscopic ultrasonographyDis Colon Rectum2005482859110.1007/s10350-004-0765-yOpen DOISearch in Google Scholar
Anthony LB, Strosberg JR, Klimstra DS, Maples WJ, O’Dorisio TM, Warner RR, et al. The NANETS consensus guidelines for the diagnosis and management of gastro- intestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum. Pancreas 2010; 39: 767-74. doi: 10.1097/MPA.0b013e3181ec1261AnthonyLBStrosbergJRKlimstraDSMaplesWJO’DorisioTMWarnerRRThe NANETS consensus guidelines for the diagnosis and management of gastro- intestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectumPancreas2010397677410.1097/MPA.0b013e3181ec1261Open DOISearch in Google Scholar
Dromain C, Déandréis D, Scoazec JY, Goere D, Ducreux M, Baudin E, et al. Imaging of neuroendocrine tumors of the pancreas. Diagn Interv Imaging 2016; 97: 1241-57. doi: 10.1016/j.diii.2016.07.012DromainCDéandréisDScoazecJYGoereDDucreuxMBaudinEImaging of neuroendocrine tumors of the pancreasDiagn Interv Imaging20169712415710.1016/j.diii.2016.07.012Open DOISearch in Google Scholar
van Essen M, Sundin A, Krenning EP, Kwekkeboom DJ. Neuroendocrine tumours: the role of imaging for diagnosis and therapy. Nat Rev Endocrinol 2014; 10: 102-14.van EssenMSundinAKrenningEPKwekkeboomDJNeuroendocrine tumours: the role of imaging for diagnosis and therapyNat Rev Endocrinol2014101021410.1038/nrendo.2013.246Search in Google Scholar
Ueno N, Tomiyama T, Tano S, Wada S, Aizawa T, Kimura K, et al. Utility of endoscopic ultrasonography with color Doppler function for the diagnosis of islet cell tumor. Am J Gastroenterol 1996; 91: 772e6. doi: 10.1038/nrendo.2013.246UenoNTomiyamaTTanoSWadaSAizawaTKimuraKUtility of endoscopic ultrasonography with color Doppler function for the diagnosis of islet cell tumorAm J Gastroenterol199691772e610.1038/nrendo.2013.246Open DOISearch in Google Scholar
Rösch T, Braig C, Gain T, Feuerbach S, Siewert JR, Schusdziarra V, et al. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology 1992; 102: 188e99. doi: 10.1016/0016-5085(92)91800-jRöschTBraigCGainTFeuerbachSSiewertJRSchusdziarraVStaging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiographyGastroenterology1992102188e9910.1016/0016-5085(92)91800-jOpen DOISearch in Google Scholar
Ramage JK, Ahmed A, Ardill J, Bax N, Breen DJ, Caplin ME, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut 2012; 61: 6-32. doi: 10.1136/gutjnl-2011-300831RamageJKAhmedAArdillJBaxNBreenDJCaplinMEGuidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)Gut20126163210.1136/gutjnl-2011-300831328086122052063Open DOISearch in Google Scholar
Cappelli C, Boggi U, Mazzeo S, Cervelli R, Campani D, Funel N, et al. Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours Eur Radiol 2015; 25: 751-9. doi: 10.1007/s00330-014-3485-2CappelliCBoggiUMazzeoSCervelliRCampaniDFunelNContrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumoursEur Radiol201525751910.1007/s00330-014-3485-225447971Open DOISearch in Google Scholar
Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch Nat Rev Cancer 2003; 3: 401-10. doi: 10.1038/nrc1093BergersGBenjaminLETumorigenesis and the angiogenic switchNat Rev Cancer200334011010.1038/nrc109312778130Open DOISearch in Google Scholar
Koito K, Namieno T, Nagakawa T, Morita K. Delayed enhancement of islet cell carcinoma on dynamic computed tomography: a sign of its malignancy. Abdom Imaging 1997; 22: 304-6.KoitoKNamienoTNagakawaTMoritaKDelayed enhancement of islet cell carcinoma on dynamic computed tomography: a sign of its malignancyAbdom Imaging199722304610.1007/s0026199001949107655Search in Google Scholar
Takumi K, Fukukura Y, Higashi M, Ideue J, Umanodan T, Hakamada H, et al. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade. Eur J Radiol 2015; 84: 1436-43. doi: 10.1016/j.ejrad.2015.05.005TakumiKFukukuraYHigashiMIdeueJUmanodanTHakamadaHPancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor gradeEur J Radiol20158414364310.1016/j.ejrad.2015.05.00526022520Open DOISearch in Google Scholar
Marin D, Nelson RC, Barnhart H, Schindera ST, Ho LM, Jaffe TA, et al. Detection of pancreatic tumors, image quality, and radiation dose during the pancreatic parenchymal phase: effect of a low-tube-voltage, high-tube-current CT technique-preliminary results. Radiology 2010; 256: 450-9. doi: 10.1148/radiol.10091819MarinDNelsonRCBarnhartHSchinderaSTHoLMJaffeTADetection of pancreatic tumors, image quality, and radiation dose during the pancreatic parenchymal phase: effect of a low-tube-voltage, high-tube-current CT technique-preliminary resultsRadiology2010256450910.1148/radiol.1009181920656835Open DOISearch in Google Scholar
Granata V, Fusco R, Catalano O, Setola SV, de Lutio di Castelguidone E, Piccirillo M, et al. Multidetector computer tomography in the pancreatic adenocarcinoma assessment: an update. Infect Agent Cancer 2016; 11: 57. doi: 10.1186/s13027-016-0105-6GranataVFuscoRCatalanoOSetolaSVde Lutiodi Castelguidone EPiccirilloMMultidetector computer tomography in the pancreatic adenocarcinoma assessment: an updateInfect Agent Cancer2016115710.1186/s13027-016-0105-6511126727891175Open DOISearch in Google Scholar
George E, Wortman JR, Fulwadhva UP, Uyeda JW, Sodickson AD. Dual energy CT applications in pancreatic pathologies. Br J Radiol 2017; 90: 20170411. doi: 10.1259/bjr.20170411GeorgeEWortmanJRFulwadhvaUPUyedaJWSodicksonADDual energy CT applications in pancreatic pathologiesBr J Radiol2017902017041110.1259/bjr.20170411604764028936888Open DOISearch in Google Scholar
Lin XZ, Wu ZY, Tao R, Guo Y, Li JY, Zhang J, et al. Dual energy spectral CT imaging of insulinoma-Value in preoperative diagnosis compared with conventional multi-detector CT. Eur J Radiol 2012; 81: 2487-94. doi: 10.1016/j. ejrad.2011.10.028LinXZWuZYTaoRGuoYLiJYZhangJDual energy spectral CT imaging of insulinoma-Value in preoperative diagnosis compared with conventional multi-detector CTEur J Radiol20128124879410.1016/j.ejrad.2011.10.02822153746Open DOISearch in Google Scholar
Van Binnebeek S, Vanbilloen B, Baete K, Terwinghe C, Koole M, Mottaghy FM, et al. Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: a lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours. Eur Radiol 2016; 26: 900-9. doi: 10.1007/s00330-015-3882-1VanBinnebeek SVanbilloenBBaeteKTerwingheCKooleMMottaghyFMComparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: a lesion-by-lesion analysis in patients with metastatic neuroendocrine tumoursEur Radiol201626900910.1007/s00330-015-3882-126162577Open DOISearch in Google Scholar
Caramella C, Dromain C, De Baere T, Boulet B, Schlumberger M, Ducreux M, et al. Endocrine pancreatic tumours: which are the most useful MRI sequences? Eur Radiol 2010; 20: 2618-27. doi: 10.1007/s00330-010-1840-5CaramellaCDromainCDe BaereTBouletBSchlumbergerMDucreuxMEndocrine pancreatic tumours: which are the most useful MRI sequences?Eur Radiol20102026182710.1007/s00330-010-1840-520668861Open DOISearch in Google Scholar
Oberg KE, Reubi JC, Kwekkeboom DJ, Krenning EP. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy. Gastroenterology 2010; 139: 742-53, 753.e1. doi: 10.1053/j. gastro.2010.07.002ObergKEReubiJCKwekkeboomDJKrenningEPRole of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapyGastroenterology201013974253753.e110.1053/j.gastro.2010.07.00220637207Open DOISearch in Google Scholar
Wang Y, Chen ZE, Yaghmai V, Nikolaidis P, McCarthy RJ, Merrick L, et al. Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging 2011; 33: 1071-9. doi: 10.1002/jmri.22541WangYChenZEYaghmaiVNikolaidisPMcCarthyRJMerrickLDiffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristicsJ Magn Reson Imaging2011331071910.1002/jmri.2254121509863Open DOISearch in Google Scholar
Devries AF, Griebel J, Kremser C, Judmaier W, Gneiting T, Kreczy A, Ofner D, Pfeiffer KP, Brix G, Lukas P. Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res 2001; 61: 2513-6.DevriesAFGriebelJKremserCJudmaierWGneitingTKreczyAOfnerDPfeifferKPBrixGLukasPTumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinomaCancer Res20016125136Search in Google Scholar
DeVries AF, Kremser C, Hein PA, Griebel J, Krezcy A, Ofner D, et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003; 56: 958-65. doi: 10.1016/s0360-3016(03)00208-6DeVriesAFKremserCHeinPAGriebelJKrezcyAOfnerDTumor microcirculation and diffusion predict therapy outcome for primary rectal carcinomaInt J Radiat Oncol Biol Phys2003569586510.1016/s0360-3016(03)00208-6Open DOISearch in Google Scholar
Bol K, Haeck JC, Groen HC, Niessen WJ, Bernsen MR, de Jong M, et al. Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model? PLoS One 2013; 8: e77076. doi: 10.1371/journal.pone.0077076BolKHaeckJCGroenHCNiessenWJBernsenMRde JongMCan DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model?PLoS One20138e7707610.1371/journal.pone.0077076379293324116203Open DOISearch in Google Scholar
Huh J, Choi Y, Woo DC, Seo N, Kim B, Lee CK, et al. Feasibility of test-bolus DCE-MRI using CAIPIRINHA-VIBE for the evaluation of pancreatic malignancies. Eur Radiol 2016; 26: 3949-56. doi: 10.1007/s00330-016-4209-6HuhJChoiYWooDCSeoNKimBLeeCKFeasibility of test-bolus DCE-MRI using CAIPIRINHA-VIBE for the evaluation of pancreatic malignanciesEur Radiol20162639495610.1007/s00330-016-4209-626809293Open DOISearch in Google Scholar
Zhao W, Quan Z, Huang X, Ren J, Wen D, Zhang G, et al. Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast-enhanced MRI. Oncol Lett 2018; 15: 8349-56. doi: 10.3892/ol.2018.8384ZhaoWQuanZHuangXRenJWenDZhangGGrading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast-enhanced MRIOncol Lett20181583495610.3892/ol.2018.8384595018129805568Open DOISearch in Google Scholar
Li Q, Ye ZX. [Radiomics: the process and applications in tumor research]. Zhonghua Zhong Liu Za Zhi 2018; 40: 801-4. doi: 10.3760/cma.j.is sn.0253-3766.2018.11.001LiQYeZX[Radiomics: the process and applications in tumor research]Zhonghua Zhong Liu Za Zhi201840801410.3760/cma.j.issn.0253-3766.2018.11.00130481928Open DOISearch in Google Scholar
Napel S, Mu W, Jardim-Perassi BV, Aerts HJWL, Gillies RJ. Quantitative imaging of cancer in the postgenomic era: Radio(geno)mics, deep learning, and habitats. Cancer 2018; 124: 4633-49. doi: 10.1002/cncr.31630NapelSMuWJardim-PerassiBVAertsHJWLGilliesRJQuantitative imaging of cancer in the postgenomic era: Radio(geno)mics, deep learning, and habitatsCancer201812446334910.1002/cncr.31630648244730383900Open DOISearch in Google Scholar
De Robertis R, Maris B, Cardobi N, Tinazzi Martini P, Gobbo S, Capelli P, et al. Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? Eur Radiol 2018; 28: 2582-91. doi: 10.1007/s00330-017-5236-7De RobertisRMarisBCardobiNTinazziMartini PGobboSCapelliPCan histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors?Eur Radiol20182825829110.1007/s00330-017-5236-729352378Open DOISearch in Google Scholar
Sidhu PS, Cantisani V, Dietrich CF, Gilja OH, Saftoiu A, Bartels E, et al. The EFSUMB guidelines and recommendations for the clinical practice of Contrast-Enhanced Ultrasound (CEUS) in Non-c hepatic applications: Update 2017 (Long Version). Ultraschall Med 2018; 39: e2-e44. doi: 10.1055/s-0044-101254SidhuPSCantisaniVDietrichCFGiljaOHSaftoiuABartelsEThe EFSUMB guidelines and recommendations for the clinical practice of Contrast-Enhanced Ultrasound (CEUS) in Non-c hepatic applications: Update 2017 (Long Version)Ultraschall Med201839e2e4410.1055/s-0044-10125429510440Open DOISearch in Google Scholar
Wang LX, Liu K, Lin GW, Jiang T. Primary hepatic neuroendocrine tumors: comparing CT and MRI features with pathology. Cancer Imaging 2015; 15: 13. doi: 10.1186/s40644-015-0046-0WangLXLiuKLinGWJiangTPrimary hepatic neuroendocrine tumors: comparing CT and MRI features with pathologyCancer Imaging2015151310.1186/s40644-015-0046-0453675726272674Open DOISearch in Google Scholar
Tan Y, Xiao EH. Rare hepatic malignant tumors: dynamic CT, MRI, and clinicopathologic features: with analysis of 54 cases and review of the literature. Abdom Imaging 2013; 38: 511-26. doi: 10.1007/s00261-012-9918-yTanYXiaoEHRare hepatic malignant tumors: dynamic CT, MRI, and clinicopathologic features: with analysis of 54 cases and review of the literatureAbdom Imaging2013385112610.1007/s00261-012-9918-y22669313Open DOISearch in Google Scholar
Rückert RI, Rückert JC, Dörffel Y, Rudolph B, Müller JM. Primary hepatic neuroendocrine tumor: successful hepatectomy in two cases and review of the literature. Digestion 1999; 60: 110-6. doi: 10.1159/000007635RückertRIRückertJCDörffelYRudolphBMüllerJMPrimary hepatic neuroendocrine tumor: successful hepatectomy in two cases and review of the literatureDigestion199960110610.1159/00000763510095151Open DOISearch in Google Scholar
Iwao M, Nakamuta M, Enjoji M, Kubo H, Fukutomi T, Tanabe Y, et al. Primary hepatic carcinoid tumor: case report and review of 53 cases. Med Sci Monit 2001; 7: 746-50.IwaoMNakamutaMEnjojiMKuboHFukutomiTTanabeYPrimary hepatic carcinoid tumor: case report and review of 53 casesMed Sci Monit2001774650Search in Google Scholar
Li W, Zhuang BW, Wang Z, Liao B, Hong LY, Xu M, et al. Case report of contrast-enhanced ultrasound features of primary hepatic neuroendocrine tumor: A CARE-Compliant Article. Medicine (Baltimore) 2016; 95: e 3450. doi: 10.1097/MD.0000000000003450LiWZhuangBWWangZLiaoBHongLYXuMCase report of contrast-enhanced ultrasound features of primary hepatic neuroendocrine tumor: A CARE-Compliant ArticleMedicine (Baltimore)201695e345010.1097/MD.0000000000003450490233427227910Open DOISearch in Google Scholar
Iimuro Y, Deguchi Y, Ueda Y, Tanaka A, Iwasa Y, Ishihara M, et al. Primary hepatic carcinoid tumor with metachronous lymph node metastasis after long-term follow up. J Gastroenterol Hepatol 2002; 17:1119-24. doi: 10.1046/j.1440-1746.2002.02663.xIimuroYDeguchiYUedaYTanakaAIwasaYIshiharaMPrimary hepatic carcinoid tumor with metachronous lymph node metastasis after long-term follow upJ Gastroenterol Hepatol20021711192410.1046/j.1440-1746.2002.02663.x12201876Open DOISearch in Google Scholar
Abdel Wahab M, Fathy O, Elghwalby N, Sultan A, Mostafa M, El-Baz M, et al. Primary hepatic carcinoid tumor: one Egyptian center experience. Hepatogastroenterology 2006 53: 33-8AbdelWahab MFathyOElghwalbyNSultanAMostafaMEl-BazMPrimary hepatic carcinoid tumor: one Egyptian center experienceHepatogastroenterology200653338Search in Google Scholar
Ronot M, Clift AK, Baum RP, Singh A, Kulkarni HR, Frilling A, Vilgrain V. Morphological and functional imaging for detecting and assessing the resectability of neuroendocrine liver metastases. Neuroendocrinology 2018; 106: 74-88. doi: 10.1159/000479293RonotMCliftAKBaumRPSinghAKulkarniHRFrillingAVilgrainVMorphological and functional imaging for detecting and assessing the resectability of neuroendocrine liver metastasesNeuroendocrinology2018106748810.1159/00047929328728155Open DOISearch in Google Scholar
Veenendaal LM, Borel Rinkes IH, Lips CJ, van Hillegersberg R. Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy. World J Surg Oncol 2006; 4: 35. doi: 10.1186/1477-7819-4-35VeenendaalLMBorel RinkesIHLipsCJvan HillegersbergRLiver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancyWorld J Surg Oncol200643510.1186/1477-7819-4-35152496216800893Open DOISearch in Google Scholar
Flechsig P, Zechmann CM, Schreiweis J, Kratochwil C, Rath D, Schwartz LH, et al. Qualitative and quantitative image analysis of CT and MR imaging in patients with neuroendocrine liver metastases in comparison to 68Ga-DOTATOC PET. Eur J Radiol 2015; 84: 1593-600. doi: 10.1016/j. ejrad.2015.04.009FlechsigPZechmannCMSchreiweisJKratochwilCRathDSchwartzLHQualitative and quantitative image analysis of CT and MR imaging in patients with neuroendocrine liver metastases in comparison to 68Ga-DOTATOC PETEur J Radiol201584159360010.1016/j.ejrad.2015.04.00925999064Open DOISearch in Google Scholar
Knigge U, Capdevila J, Bartsch DK, Baudin E, Falkerby J, Kianmanesh R, et al. ENETS consensus recommendations for the standards of care in neuroendocrine neoplasms: follow-up and documentation. Neuroendocrinology 2017; 105: 310-9. doi: 10.1159/000458155KniggeUCapdevilaJBartschDKBaudinEFalkerbyJKianmaneshRENETS consensus recommendations for the standards of care in neuroendocrine neoplasms: follow-up and documentationNeuroendocrinology2017105310910.1159/00045815528222443Open DOISearch in Google Scholar
Singh S, Moody L, Chan DL, Metz DC, Strosberg J, Asmis T, et al. Follow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumors. JAMA Oncol 2018; 4: 1597-604. doi: 10.1001/jamaon-col.2018.2428SinghSMoodyLChanDLMetzDCStrosbergJAsmisTFollow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumorsJAMA Oncol20184159760410.1001/jamaon-col.2018.2428Open DOISearch in Google Scholar
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-47. doi: 10.1016/j.ejca.2008.10.026EisenhauerEATherassePBogaertsJSchwartzLHSargentDFordRNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer2009452284710.1016/j.ejca.2008.10.02619097774Open DOISearch in Google Scholar
Kim KW, Krajewski KM, Nishino M, Jagannathan JP, Shinagare AB, Tirumani SH, et al. Update on the management of gastroenteropancreatic neuroendocrine tumors with emphasis on the role of imaging. AJR Am J Roentgenol 2013; 201: 811-24. doi: 10.2214/AJR.12.10240KimKWKrajewskiKMNishinoMJagannathanJPShinagareABTirumaniSHUpdate on the management of gastroenteropancreatic neuroendocrine tumors with emphasis on the role of imagingAJR Am J Roentgenol20132018112410.2214/AJR.12.10240397026524059370Open DOISearch in Google Scholar
